Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy

Table 3 Frequency of Intervention Group Participants Scoring Above the Pre-Specified Symptom Severity Thresholds to Prompt Receipt of ESRA-C Self-Care Messages (N = 108)

Outcome	Cut Point	T1	T2	T3/4
Physical Function	QLQ – C30 Physical Function Subscale ≤50	2 (2%)	5 (5%)	5 (5%)
Sensory CIPN	QLQ – CIPN20 Sensory Subscale ≥ 50	1 (1%)	2 (2%)	3 (3%)
Motor CIPN	QLQ – CIPN20 Motor Subscale ≥50	2 (2%)	3 (3%)	4 (4%)
Current Pain Intensity	Pain Intensity Numerical Rating Scale ≥5 and/or Symptom Distress Pain Intensity Item ≥ 3^a	18 (17%)	23 (21%)	18 (17%)
Fatigue	Symptom Distress Scale Fatigue Item ≥ 3^a	30 (28%)	48 (44%)	34 (32%)^b
Insomnia	Symptom Distress Scale Insomnia Item ≥ 3^a	23 (22%)^c	33 (31%)	18 (17%)
Depression	Patient Health Questionnaire – 9 ≥ 10	15 (14%)	12 (11%)	10 (9%)

This table describes the number of intervention group participants who scored above the pre-specified threshold associated with each patient-reported outcome measure that prompted receipt of symptom specific ESRA-C self-care messages
^aSymptom Distress Scale – 15 Items [23, 61] scored from 1 to 5, with higher scores representing worse symptoms
^bn = 107
^cn = 105

ISSN: 1471-2407